About Elucid
Elucid is a company based in Boston (United States) founded in 2013 by James Hamilton and Andrew J Buckler.. Elucid has raised $151.87 million across 7 funding rounds from investors including Elevage Medical Technologies, MedTex Ventures and IAG Capital Partners. Elucid operates in a competitive market with competitors including Vista.ai, Circle Cardiovascular Imaging, Volta Medical, UltraSight and Us2.ai, among others.
- Headquarter Boston, United States
- Founders James Hamilton, Andrew J Buckler
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Elucid Bioimaging Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$151.87 M (USD)
in 7 rounds
-
Latest Funding Round
$36.5 M (USD), Series C
Oct 10, 2025
-
Investors
Elevage Medical Technologies
& 7 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Elucid
Elucid has successfully raised a total of $151.87M across 7 strategic funding rounds. The most recent funding activity was a Series C round of $36.5 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series C — $36.5M
-
First Round
First Round
(28 Aug 2013)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2025 | Amount | Series C - Elucid | Valuation |
investors |
|
| Oct, 2023 | Amount | Series C - Elucid | Valuation | Elevage Medical Technologies |
|
| Jun, 2022 | Amount | Series B - Elucid | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Elucid
Elucid has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Elevage Medical Technologies, MedTex Ventures and IAG Capital Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Venture capital investments are provided by IAG Capital Partners.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Elucid
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Elucid
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Elucid Comparisons
Competitors of Elucid
Elucid operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Vista.ai, Circle Cardiovascular Imaging, Volta Medical, UltraSight and Us2.ai, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-guided software is utilized to automate MRI exams for clinicians.
|
|
| domain | founded_year | HQ Location |
Software for cardiac MR and CT image evaluation is provided.
|
|
| domain | founded_year | HQ Location |
AI-based cardiac mapping assistance software is developed.
|
|
| domain | founded_year | HQ Location |
AI platform for ultrasound diagnosis of cardiac disorders is offered.
|
|
| domain | founded_year | HQ Location |
Heart risk is detected using AI-powered echocardiogram analysis.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Elucid
Frequently Asked Questions about Elucid
When was Elucid founded?
Elucid was founded in 2013.
Where is Elucid located?
Elucid is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Who is the current CEO of Elucid?
Blake Richards is the current CEO of Elucid.
Is Elucid a funded company?
Elucid is a funded company, having raised a total of $151.87M across 7 funding rounds to date. The company's 1st funding round was a Series B of $27M, raised on Aug 28, 2013.
What does Elucid do?
Elucid was founded in 2013 and is headquartered in Boston, United States. AI-driven software for arterial analysis is provided to healthcare providers, supporting clinical diagnostic processes. Features are included for clinical research, personalized patient care, and stroke prediction. Operations focus on medical imaging and diagnostic tools within the health technology sector.
Who are the top competitors of Elucid?
Elucid's top competitors include Vista.ai, Us2.ai and Volta Medical.
Who are Elucid's investors?
Elucid has 8 investors. Key investors include Elevage Medical Technologies, MedTex Ventures, IAG Capital Partners, BlueStone Venture Partners, and Biovision Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.